chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pain at injection site, Covid arm rash, itching, severely swollen underarm lymph node under injection site
INJECTION SITE STINGING AND PAIN WEAKNESS  TIREDNESS EXTREME CHILLS EVENT LASTED 21 HOURS
I've been vertigo; I've been ringing in my ears; This case was reported by a consumer via interactive digital media and described the occurrence of vertigo in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vertigo and ringing in ears. On an unknown date, the outcome of the vertigo and ringing in ears were not recovered/not resolved.   It was unknown if the reporter considered the vertigo and ringing in ears to be related to Shingrix.     Additional Information: GSK Receipt Date: 24-MAY-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient had been experiencing vertigo and ringing in ears since taking first dose of Shingrix vaccine. The patient asked if he/she should still get a second dose of Shingrix vaccine. Additional supportive information: The follow-up would not possible as no contact details were available.
Pt received vaccine at 12:27pm. Pt C/O chest tightness / tingling and lightheadedness at 12:43pm. Pt took 2 puffs of home inhaler. BP 168/70 HR 96 SPO2 100%. Pt then c/o itchiness at 12:45pm. No wheezing or stridor noted. Pt instructed to take her own EPi Pen. Epi Pen administered at 12:45pm. RRT called, pt escorted to ED with RRT team.
Patient recived Pfizer vaccine as second dose instead of Moderna which she recieved as first dose. Patent was assessed by PCP and denied any symptoms or abnormalties.
Symptoms progressively got worse; She did not eat; Tiredness; Weakness; Feeling unwell; Nauseated/Nauseous; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Apr2021 (Lot number: EW0176) at the age of 80 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot number: ER8730 , Route of administration: Injection in the left), administration date: 30Mar2021, when the patient was 80 years old, for Covid-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset 07May2021, outcome "not recovered", described as "Tiredness"; ASTHENIA (non-serious) with onset 07May2021, outcome "not recovered", described as "Weakness"; MALAISE (non-serious) with onset 07May2021, outcome "not recovered", described as "Feeling unwell"; NAUSEA (non-serious) with onset 07May2021, outcome "not recovered", described as "Nauseated/Nauseous"; DECREASED APPETITE (non-serious) with onset 09May2021, outcome "not recovered", described as "She did not eat"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "Symptoms progressively got worse".  Additional information: Patient reported that her symptoms progressively got worse and on 09May2021 she did not eat. She did eat today, but still does not feel like eating. She started out feeling tired like she did not sleep enough or needed more coffee and stated that nothing worked.  No follow-up attempts are possible. No further information is expected.
Mother reports pain at the site, fever of 101-102 degrees Fahrenheit, headache, and general "bad feeling". Patient has been taking ibuprofen every four hours. NP recommended Tylenol every 4-6 hours, for 2-3 days, and cool compresses to the site. NP recommended seeking medical attention if the fever were to climb above 102 or the headache worsens, with medication. We will follow up with the patient in three days.
15 minutes after receiving the vaccine I felt like I was going to faint and then called out somone?s name and she came and caught me as I fainted. They called for Rapid Response Team.   They put me on a stretcher, asked what happened, and took some vital signs - I was tachycardic, BP was 184/108 pulse ox 97 and they also saw nystagmus only in my left eye which I?ve never had before.
Day 7 (post vaccine) - swelling, redness, heat and pain at injection site. Also developed associated Lymphangitis. Treated as presumptive cellulitis.
sore arm; sleepy; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy). On 29-Jan-2021, PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
Not able to walk anymore; Can't get from the front door to the car; Trembling like she has Parkinson's; can't turn over in bed; she's hurting; Face swollen; Fever; Joints started hurting; leg and hips; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Face swollen), GAIT INABILITY (Not able to walk anymore), MOBILITY DECREASED (Can't get from the front door to the car), TREMOR (Trembling like she has Parkinson's) and DISCOMFORT (can't turn over in bed; she's hurting) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included TRAMADOL and MELOXICAM (MOBIC) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced PYREXIA (Fever ) and ARTHRALGIA (Joints started hurting; leg and hips). On 21-Jan-2021, the patient experienced SWELLING FACE (Face swollen). On an unknown date, the patient experienced GAIT INABILITY (Not able to walk anymore), MOBILITY DECREASED (Can't get from the front door to the car), TREMOR (Trembling like she has Parkinson's) and DISCOMFORT (can't turn over in bed; she's hurting). On 21-Jan-2021, PYREXIA (Fever ) outcome was unknown. At the time of the report, SWELLING FACE (Face swollen), GAIT INABILITY (Not able to walk anymore), MOBILITY DECREASED (Can't get from the front door to the car), TREMOR (Trembling like she has Parkinson's), DISCOMFORT (can't turn over in bed; she's hurting) and ARTHRALGIA (Joints started hurting; leg and hips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient experienced face swollen and took her to Urgent Care. They gave her a shot (didn't give the name). The night of the first dose, her joints started hurting; leg and hips and was not able to walk anymore. She can't get from the front door to the car. She's on a walker and was taken to an orthopedic. But continued to get worse in her joints. She went from walking 2 miles a day to not walking. She was taken to a specialist in Birmingham. She can't turn over in bed and was hurting. She can't hold a pen for writing.    This case was linked to MOD-2021-168525 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-May-2021 and contains non significant information.
Mom called on 11-4-05 at 16:59 to report child receiving 3 shots on Wednesday. She states the injection site 1st had tiny red bumps on the left leg and now its the size of baseball.
Pt discovered rash when she removed band aid the next AM, rash is just around injection site and has not enlarged since midday on 10/21/13; some itching (recommended Benadryl and Cortisone cream). Zostavax inj site only.
I'm experiencing uncontrollable high spike in my blood sugar readings. I'm a type 2 Diabetic and was diagnosed with this condition in December of 2015. Prior to the vaccine my A1C (as of March 2021) was 5.9 (pre-diabetic status) and my blood sugars were less than 140 prior to second vaccine. Post vaccine my numbers have been averaging between 200 to 480. This all occurred with no significant change to my diet. I notified my physician 3 days post vaccine and she advised that I allow a little more time for the inflammation to calm down which may be the reason for my increased high blood sugar readings. After 1-2 weeks I reached out again my Dr. again and she advised to allow an additional 6 weeks and requested that I come in the office for lab testing. I reached out to her again and she prescribed additional medicine (Glipizide) 2.5 mg , then 5.0mg with the first week then 10.0 mg second week and  it's now my 3rd week on additional medication to my (Metformin 1000 mg twice a day) as of today 8/4/21 I'm starting 20 mg. The reason for the constant increases in mg is because so far the medicine is doing nothing to reduce my numbers. I have never experienced high blood sugars like this in a constant matter. My A1C went from 5.9 in March of 2021, to 9.3 as of July 14, 2021. I feel this is a direct adverse affect from the 2nd vaccine. I have no funds to afford better diabetic medication to assist in bringing my numbers down and my Dr. is unable to obtain free samples from a manufacturer due to Clinic guidelines.
This spontaneous report was received from a physician via a company representative and refers to a 10-year-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On unknown dates, the patient was vaccinated with two doses of M-M-R II injection (dose, route of administration, lot number and expiration date were not reported) as a standard of care. On an unknown date, the patient experienced mumps. The company representative added, there was a mumps outbreak at the patient's area. The outcome of the event was unknown. The relatedness between the event M-M-R II was not reported.
No symptoms or side effects reported; HCP called to report that a dose of PROQUAD, Lot: X007358 Expiration: 9/8/2024, was delivered to a 36-year-old female patient on 10/9/2023. No symptoms or side effects reported. HCP gives permission to contact. No further AE information available. No; This spontaneous report was received from a nurse and refers to a 36-year-old female patient. No information on patient's medical history, current conditions and concomitant medications was provided.  On 09-OCT-2023 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (albumin status: rHA) lot # X007358 and expiration date 08-SEP-2024, 0.5 milliliter for prophylaxis (dose number, route and site of administration were not provided) (product administered to patient of inappropriate age and no adverse event).
This spontaneous report has been received from a practice manager referring to a patient of unknown age. Information about concomitant medications, concurrent conditions, and medical history was not provided. On 05-SEP-2018, the patient were vaccinated with improperly stored PROQUAD (strength, dose number, anatomical location, route of administration were unknown; lot # R006216 and expiration date 28-AUG-2019) for prophylaxis. No adverse effects were reported. The reporter reported multiple temperature excursions over the past year and a half found during an audit. The excursion temperature in 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017; 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 5-JUL-2018, 15-AUG-2018 was 6 degree Celsius for max 8.75 hours. In 02-MAR-2018 and 27-AUG-2018 was 7 degree Celsius for max 8.75 hours. In 07-DEC-2017 was 8 degree Celsius for max 15 hours. In Data logger was not involved. Sender's Comments: US-009507513-1809USA003709; US-009507513-1810USA001951; US-009507513-1810USA001952; US-009507513-1810USA001953; US-009507513-1810USA001955; US-009507513-1810USA001956; US-009507513-1810USA001957; US-009507513-1810USA001958; US-009507513-1810USA001959.
patient developed redness at the injection site 1 week after immunization followed by an L-shaped rash few centimeters distal to the injection site which lasted for 4 days and required a steroid injection 2 days after appearance.  Currently, patient doesn't have any rash and her symptoms have resolved
history of seasonal allergies presents clinic today with acute onset of sore throat, an increased sinus congestion in the last 2-3 days, starting on 9/26/21
Less than an hr after the vaccine I suffered a gushing bloody nose.  About 10pm I started having at gurgling, discomfort feeling in my stomach which had me in the restroom all night followed by fever and diarrhea.  On 12/31 I was sent for a COVID test and results on 1/1 showed that I was positive resulting in me being out of work for a total of 3 weeks.  And as of today I am still experience mild  COVID like symptoms
MD rpt pt recv 2nd dose of varivax 5/4/98 & subsequently devel ``1 blister & a low grade fever''. pt became preg & pt prenatal course was complicated by exposure to CMV the 1st trimester & an unspecified venereal disease.deliv norm baby
OFF LABEL DOSING FREQUENCY; This spontaneous report received from a patient concerned a female of unspecified age and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient never had covid-19. The patient previously received first dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin was not reported, batch number: 1808609, expiry: Unknown) dose was not reported, 1 total, administered at left arm on 30-MAR-2021 for covid-19 prophylaxis.  No adverse events were reported following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received second dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin was not reported, batch number: 1822811, expiry: Unknown) dose was not reported, 1 total (first booster) administered at left arm on 26-OCT-2021 for covid-19 prophylaxis.  No adverse events were reported following vaccination with second dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2). The patient received third dose of covid-19 vaccine ad26.cov2.s (Dose number in series 3) (suspension for injection, route of admin not reported, batch number: 1855190, expiry: UNKNOWN) dose was not reported, 1 total (second booster) administered at left arm on 24-MAY-2022 for covid-19 prophylaxis, which was off label use (off label dosing frequency) with no other side effects (Dose number in series 3). No concomitant medications were reported.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of off label dosing frequency was not reported. This report was non-serious. This report was linked as same reporter to 20220924630.
Approx 20 blistered areas on legs and abd fever 101.1. Zovirax 20/5 1tsp po daily x 5 d.
Fever started out at 102. One month later 105 fever that would not go down. Continued with daily fevers of 100-102 for the next 7 months. Fevers a currently gone. RA type symptoms the entire time.
Refridgeration excursions identified; No adverse event; Vaccine that underwent temperature excursions could have been administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine that underwent temperature excursions could have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event) in a 5-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Aug-2022 at 5:05 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 04-Aug-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine that underwent temperature excursions could have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine that underwent temperature excursions could have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Vaccine that underwent temperature excursions could have been administered to patient) and PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified).    It was unknown if the patient ever been diagnosed with or tested positive for COVID-19. No concomitant medication were reported.  Patient took second, third and fourth dose through intramuscularly at deltoid region. The vaccines were stored in the Refrigerator. There were 2 unbroken cartons with 20 vials. The vials of both monovalent vaccines were moved from freezer to refrigerator on 07-Sep-2022. All the vials were not visualized. The patient administered the vaccine in the deltoid (unspecified location) muscle. Refridgeration excursions identified, state vaccine was housed in these units. There were excursions noted.         No treatment information was provided by the reporter.
BODY HOT; BODY ACHES; CHILLS; FEVER; HEADACHE; NAUSEA; SWEAT; This spontaneous report received from a patient concerned an 18 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, food allergy, seasonal allergies, and animal allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number not reported) dose was not reported, administered on 02-APR-2021 17:45 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced sweat. On 02-APR-2021 22:45, the subject experienced body hot. On 02-APR-2021 22:45, the subject experienced body aches. On 02-APR-2021 22:45, the subject experienced chills. On 02-APR-2021 22:45, the subject experienced fever. On 02-APR-2021 22:45, the subject experienced headache. On 02-APR-2021 22:45, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body hot, body aches, chills, fever, and nausea on 07-APR-2021, and had not recovered from headache, and sweat. This report was non-serious.
Red raised rash 2" x 3" on left arm, warm to touch. Itchy throat like when patient had allergic reaction to amoxicillin in past. BENADRYL 50 ml on 9/21 1030am.
Sore shoulder that day, next day in afternoon started having diarrhea for two days in a row.
Information has been received from a physician concerning a 31 day old male patient (4.5 weeks of age also reported as 2 day of age), who on 12-JUL-2010 was inadvertently given the first dose of ROTATEQ (lot number: 668123/0512Z, orally at 4.5 weeks of age instead of 6 weeks (lot number: 668123/0512Z). Concomitant therapy included RECOMBIVAX HB (manufacturer unspecified). No adverse effects were reported. The patient did not seek medical attention. Follow up information has been received from the physician who reported that 31 day old male patient who on 12-JUL-2010 at 15:00 p.m., was vaccinated IM with a second dose of RECOMBIVAX HB in the left thigh (lot number: 663280/1677X). The physician reported that no adverse events noted, just given the vaccine earlier that recommended age. Additional information is not expected.
Woke up with chills, muscle pain through out whole body, fatigued and just flu like feeling. Felt like that, all day. Around 6:30pm she came outside to get some fresh air, trying to feel normal & got suddenly dizzy & then fainted. Her body kind of, rocked. She came to, after she heard her sister, calling her name a few times. So she was out for less than a minute. But she's never fainted before!
Pt developed large area of redness covering most of triceps c/o itching and burning.
Weakness - redness - heat - itch - soreness - light tightness in throat.
chills the next day; knot in the arm at injection site soreness of the whole arm; knot in the arm at injection site soreness of the whole arm; Light headed; Rash lower arm and wrist; Fever for a few hours after injection, chills the next day; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old male patient received BNT162B2, ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution of injection Lot Number: EN5318), via an unspecified route of administration, administered in Arm Left on 18Feb2021 14:00 as dose 2, single for covid-19 immunization. The patient did not have any known allergies. The patient Medical history included diabetes mellitus The patient previously received a dose of BNT162B2, ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution of injection Lot Number: EN5318), via an unspecified route of administration, administered in Arm Right on 28Jan2021 at 02:00PM as dose 1, single for covid-19 immunization. The patient did not receive any other vaccine in 4 weeks. The patient did not have COVID prior to vaccination.The patient did not have COVID post vaccination. Concomitant medications included METFORMIN HCL taken for an unspecified indication, start and stop date were not reported; nebivolol hydrochloride (BYSTOLIC) taken for an unspecified indication, start and stop date were not reported. On 18Feb2021, at 14:30, the patient experienced knot in the arm at injection site soreness of the whole arm (pain in extremity), light headed (dizziness), rash lower arm and wrist and fever for a few hours after injection. On 19Feb2021, the next day the patient was having chills. The patient did not receive any treatment for the events. The clinical outcome of the events recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.  .
Soldier was given Smallpox vaccination on 4/24/07 in error. SM has diagnoses of dermatitis. No adverse events have been noted since vaccine administration. Orders given for Claritin, Hydrocortizone 0.05% cream bid as needed.
Immediate warmth, dizziness, mild nausea, and progession to tunnel vision after her shot. She had a sensation of rapid heart beat with a normal range pulse here in observation. She was very anxious and hesitant to come for the vaccine. BP was initially high for her, 162/87, with a pulse of 79.  Normal O2 sats.  BP improved with observation.  Classic Anxiety/Panic symptoms with mild vasovagal symptoms.   All resolved. patient to exit with wheelchair and staff
Day 2: chills, very achy, fatigued Day 14: solid, dark purple/red discoloration across tops of both feet up to ankle, same as after shot #1 on Day 4. Not a raised area, just under surface of skin.
Dizzy, light headed, fever, body aches and chills, exhaustion, and headache all started morning after shot.
Severe Shoulder pain lasting through the night, without sleep.  Took 500 mg Tylenol around 05:00.  Helped until wears off.  Took Advil at 11:00 to ease pain.
redness and soreness reported to pharmacy the day after vaccine administered. patient will monitor for worsening signs of reaction. patient will take OTC benadryl and will report back to pharmacy if symptoms do not improve